Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1272-1277

  Kwai, Natalie C G ^a   Arnold, Ria ^a   Wickremaarachchi, Chathupa ^a   Lin, Cindy S Y ^a   Poynten, Ann M ^b   Kiernan, Matthew C ^a,c   Krishnan, Arun V ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; SODIUM CHANNEL;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PROTEIN FUNCTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SODIUM CHANNELOPATHY; SODIUM CONDUCTANCE; STRENGTH DURATION TIME CONSTANT; TOTAL NEUROPATHY SCORE;

AXONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 84876811381     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1310     Document Type: Article

References (39)

1. National Association of Diabetes Centres. Australian National Diabetes Information Audit and Benchmarking (ANDIAB) Project Report. Australian Capital Territory, National Association of Diabetes Centres, 2010, p. 174
2. Sugimoto K, Murakawa Y, Sima AAF. Diabetic neuropathyda continuing enigma. Diabetes Metab Res Rev 2000;16:408-433
3. Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy-and foot ulcer-specific quality of life instrument. Diabetes Care 2003;26: 2549-2555 (Pubitemid 37052098)
4. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;19(Suppl. 1):S2-S8 (Pubitemid 36285366)
5. Maneuf YP, Hughes J, McKnight AT. Gaba-pentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices. Pain 2001;93:191-196 (Pubitemid 32568405)
6. Lenkey N, Karoly R, Lukacs P, et al. Classification of drugs based on properties of sodium channel inhibition: A comparative automated patch-clamp study. PLoS One 2010. Available from http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0015568
7. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009;27: 95-112
8. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012;153:1193-1198
9. Vinik AI. Diabetic neuropathy: patho-genesis and therapy. Am J Med 1999;107: 17S-26S
10. Mogyoros I, Kiernan MC, Burke D, Bostock H. Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain 1997; 120:317-325 (Pubitemid 27107664)
11. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996;119:439-447 (Pubitemid 26149359)
12. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: A new approach in clinical testing. Muscle Nerve 2000;23:399-409 (Pubitemid 30126986)
13. Nodera H, Kaji R. Nerve excitability testing and its clinical application to neuro-muscular diseases. Clin Neurophysiol 2006;117:1902-1916 (Pubitemid 44247879)
14. Misawa S, Kuwabara S, Ogawara K, Kitano Y, Yagui K, Hattori T. Hypergly-cemia alters refractory periods in human diabetic neuropathy. Clin Neurophysiol 2004;115:2525-2529 (Pubitemid 39304147)
15. Krishnan AV, Kiernan MC. Altered nerve excitability properties in established diabetic neuropathy. Brain 2005;128:1178-1187 (Pubitemid 40675471)
16. Misawa S, Sakurai K, Shibuya K, et al. Neuropathic pain is associated with increased nodal persistent Na(+) currents in human diabetic neuropathy. J Peripher Nerv Syst 2009;14:279-284
17. Krishnan AV, Lin CS, Kiernan MC. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 2008;131:1209-1216
18. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology 1999;53: 1660-1664 (Pubitemid 29530336)
19. Sung J-Y, Park SB, Liu Y-T, et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes 2012;61:1592-1598
20. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neuro-physiol 2001;112:1575-1585 (Pubitemid 32763239)
21. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997;498: 277-294 (Pubitemid 27056895)
22. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol 1983;341:59-74 (Pubitemid 13028523)
23. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000;123:2542-2551
24. Krishnan AV, Lin CS, Park SB, Kiernan MC. Axonal ion channels from bench to bedside: A translational neuroscience perspective. Prog Neurobiol 2009;89:288-313
25. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29: 1518-1522 (Pubitemid 44127574)
26. Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care 2008; 31:316-321 (Pubitemid 351213343)
27. Vileikyte L, Boulton A. Assessing Quality Of Life In Diabetic Neuropathy: Condition-Specific Or Generic Approach? J Peripher Nerv Syst 2000;5:180-181
28. Misawa S, Kuwabara S, Kanai K, et al. Axonal potassium conductance and gly-cemic control in human diabetic nerves. Clin Neurophysiol 2005;116:1181-1187
29. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and-resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem 2004;279: 29341-29350 (Pubitemid 38915812)
30. Craner MJ, Klein JP, Renganathan M, Black JA, Waxman SG. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann Neurol 2002;52:786-792 (Pubitemid 35403189)
31. Hong S, Wiley JW. Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat. Biochem Biophys Res Commun 2006;339:652-660 (Pubitemid 41739717)
32. Spadoni F, Hainsworth AH, Mercuri NB, et al. Lamotrigine derivatives and riluzole inhibit INa, P in cortical neurons. Neuroreport 2002;13:1167-1170 (Pubitemid 34722046)
33. Lenkey N, Karoly R, Epresi N, Vizi E, Mike A. Binding of sodium channel inhibitors to hyperpolarized and depolarized conformations of the channel. Neurophar-macology 2011;60:191-200
34. 3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat. Br J Pharmacol 2004;141:574-579 (Pubitemid 38453249)
35. Cardoso S, Carvalho C, Santos R, et al. Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synapto-somal neurotransmitters. Synapse 2011; 65:457-466
36. Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57:451-462 (Pubitemid 34477042)
37. Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res 2009;1268:154-161
38. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83: 389-400
39. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004;110:628-638 (Pubitemid 39036794)